PDCD1 and colorectal carcinoma: A recent study in mouse models of spontaneous multi-organ metastasis in MSI-H CRC tumors showed that ICIs of anti-PD-1 treatment significantly reduced the growth of primary tumors and liver metastases, and therapy efficacy correlated with the formation of TLSs in ICI-responding tumors.